255 related articles for article (PubMed ID: 31104272)
1. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition.
El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272
[TBL] [Abstract][Full Text] [Related]
2. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
[TBL] [Abstract][Full Text] [Related]
3. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
4. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
5. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
6. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic efficacy of serum and urinary netrin-1 in the early detection of diabetic nephropathy.
Elkholy RA; Younis RL; Allam AA; Hagag RY; Abdel Ghafar MT
J Investig Med; 2021 Aug; 69(6):1189-1195. PubMed ID: 33863755
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
9. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
10. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor and podocin predict nephropathy progression in type 2 diabetic patients through interaction with the autophagy influencer ULK-1.
El-Shazly AAA; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
J Diabetes Complications; 2019 Feb; 33(2):128-133. PubMed ID: 30545560
[TBL] [Abstract][Full Text] [Related]
12. ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy.
Sulaj A; Kopf S; Gröne E; Gröne HJ; Hoffmann S; Schleicher E; Häring HU; Schwenger V; Herzig S; Fleming T; Nawroth PP; von Bauer R
J Diabetes Complications; 2017 Jun; 31(6):1058-1065. PubMed ID: 28325697
[TBL] [Abstract][Full Text] [Related]
13. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
14. Potential Role of N-Cadherin in Diagnosis and Prognosis of Diabetic Nephropathy.
Ali H; Abu-Farha M; Hammad MM; Devarajan S; Bahbahani Y; Al-Khairi I; Cherian P; Alsairafi Z; Vijayan V; Al-Mulla F; Attar AA; Abubaker J
Front Endocrinol (Lausanne); 2022; 13():882700. PubMed ID: 35712247
[TBL] [Abstract][Full Text] [Related]
15. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.
Li B; Tian X; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
Int Urol Nephrol; 2020 Nov; 52(11):2145-2152. PubMed ID: 32661627
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
17. Brachial-Ankle Pulse Wave Velocity as a Novel Modality for Detecting Early Diabetic Nephropathy in Type 2 Diabetes Patients.
Zhang X; Bai R; Zou L; Zong J; Qin Y; Wang Y
J Diabetes Res; 2021; 2021():8862573. PubMed ID: 33628837
[TBL] [Abstract][Full Text] [Related]
18. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
19. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
[TBL] [Abstract][Full Text] [Related]
20. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy.
Al-Kafaji G; Al-Muhtaresh HA
Mol Med Rep; 2018 Jul; 18(1):1171-1180. PubMed ID: 29845236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
